Extract from the Register of European Patents

EP About this file: EP0071399

EP0071399 - Substituted pyrrolidine cardiovascular system regulators and antihypertensives, their preparation and use [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  16.09.1985
Database last updated on 14.03.2026
Most recent event   Tooltip07.07.2007Change - inventorpublished on 08.08.2007  [2007/32]
Applicant(s)For all designated states
SYNTEX (U.S.A.) INC.
3401 Hillview Avenue Palo Alto
California 94303 / US
[N/P]
Former [1983/06]For all designated states
SYNTEX (U.S.A.) INC.
3401 Hillview Avenue
Palo Alto California 94303 / US
Inventor(s)01 / Muchowski, Joseph Martin
1720 Banff Drive
Sunnyvale California 93087 / US
02 / Greenhouse, Robert James
277 Pacifico Ap. C301
Coyoacan Mexico D.F. / MX
03 / Ackrell, Jack
192 Webster Street
Palo Alto California 94301 / US
04 / Li, Tsung-Tee
26440 Anacapa Drive
Los Altos Hills California 94022 / US
05 / Pfister, Jurg Roland
1500 Oak Avenue
Los Altos California 94022 / US
[1983/06]
Representative(s)Armitage, Ian Michael, et al
Mewburn Ellis LLP
York House
23 Kingsway
London WC2B 6HP / GB
[N/P]
Former [1983/06]Armitage, Ian Michael, et al
MEWBURN ELLIS York House 23 Kingsway
London WC2B 6HP / GB
Application number, filing date82303835.121.07.1982
[1983/06]
Priority number, dateUS1981028589222.07.1981         Original published format: US 285892
[1983/06]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0071399
Date:09.02.1983
Language:EN
[1983/06]
Type: A3 Search report 
No.:EP0071399
Date:07.12.1983
Language:EN
[1983/49]
Search report(s)(Supplementary) European search report - dispatched on:EP03.10.1983
ClassificationIPC:C07D207/08, C07D207/09, C07D405/06, A61K31/40
[1983/06]
CPC:
C07D207/08 (EP); C07D207/00 (KR); A61P11/08 (EP);
A61P9/00 (EP); C07C217/62 (EP); C07C43/23 (EP);
C07C45/673 (EP); C07C45/676 (EP); C07D207/06 (EP);
C07D207/09 (EP); C07D207/20 (EP); C07D295/108 (EP);
C07D303/36 (EP); C07D405/06 (EP) (-)
C-Set:
C07C45/673, C07C49/223 (EP);
C07C45/676, C07C49/255 (EP)
Designated contracting statesAT,   BE,   CH,   DE,   FR,   GB,   IT,   LI,   LU,   NL,   SE [1983/06]
TitleGerman:Substituierte Pyrrolidin-Cardiogefässsystem-Regulatoren und blutdrucksenkende Mittel, ihre Herstellung und Verwendung[1983/06]
English:Substituted pyrrolidine cardiovascular system regulators and antihypertensives, their preparation and use[1983/06]
French:Pyrrolidines substituées comme régulateurs du système cardiovasculaire et agents antihypertensifs, leur fabrication et leur utilisation[1983/06]
File destroyed:13.07.1991
Examination procedure19.01.1984Examination requested  [1984/14]
18.12.1984Despatch of a communication from the examining division (Time limit: M04)
30.04.1985Application deemed to be withdrawn, date of legal effect  [1985/47]
03.06.1985Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [1985/47]
Fees paidRenewal fee
19.07.1984Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XP] EP0050370  (USV PHARMA CORP et al.)
 [AD] EP0010460  (PHARMINDUSTRIE et al.)
 [AD] EP0022408  (ROUSSEL UCLAF et al.)
 [A] US3941796  (SANKEY GEORGE H et al.)
 [A] DE2317710  (LILLY CO ELI et al.)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.